MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    The spectrum of GBA mutations in the Korean population with Parkinson’s disease

    J. Hwangbo, J. Lee, SC. Cheon, KS. Park (Yangsan, Republic of Korea)

    Objective: We investigated the mutation spectrum of glucocerebrosidase (GBA) gene in Korean patients with Parkinson’s disease (GBA-PD). Background: Mutations in the GBA gene represent important…
  • 2023 International Congress

    Hand to mouth: differences between musicians’ hand and embouchure dystonia

    A. Lee, J. Doll-Lee, E. Altenmüller (Hannover, Germany)

    Objective: To assess differences in playing ability and outcome of patients with Musician’s Hand (FHD) and Embouchure Dystonia (ED). Background: Musician’s Dystonia (MD) is a…
  • 2023 International Congress

    Gut microbiota dysbiosis in Parkinson’s disease patients: a potential biomarker of disease severity and progression?

    R. Cerroni, M. Conti, M. Pierantozzi, V. D'Angelo, N. Mercuri, A. Teofani, D. Pietrucci, G. Chillemi, V. Unida, A. Stefani (Rome, Italy)

    Objective: To investigate gut microbiota alterations in Parkinson's disease (PD) along disease progression. Background: Gut microbiota dysbiosis is considered a hallmark in PD1. However, it is…
  • 2023 International Congress

    Speech, gait and vestibular instrumental assessment in CANVAS: a case series.

    G. Di Rauso, F. Cavallieri, V. Fioravanti, E. Monfrini, A. Gessani, I. Campanini, A. Merlo, A. Castellucci, D. Ronchi, M. Napoli, R. Pascarella, S. Grisanti, R. Sabadini, C. Zini, A. Di Fonzo, F. Valzania (Modena, Italy)

    Objective: To describe through a systematic clinical-instrumental approach speech, gait and vestibular alterations in cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS). Background: CANVAS…
  • 2023 International Congress

    A new era in etiologies of chorea

    D. Biederko, M. Bennun Caller, L. Franken, R. Djaldetti (Petah Tikva, Israel)

    Objective: To describe the prevalence, presentation and etiology of chorea (including ballism and athetosis) in adults as seen at a tertiary medical center in Israel…
  • 2023 International Congress

    NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease.

    H. Berven, S. Kverneng, E. Sheard, M. Søgnen, S. Geijerstam, K. Haugarvoll, GO. Skeie, C. Dölle, C. Tzoulis (Bergen, Norway)

    Objective: To determine the safety of oral nicotinamide riboside (NR) 3000 mg daily for 4 weeks in Parkinson’s disease (PD). Secondary objectives: To assess NRs…
  • 2023 International Congress

    Expiratory strength in Parkinson’s disease patients? Does time matter?

    R. Guimaraes, F. Cendes, L. Paiva, MF. Satollo, M. Diogo, L. Durans (Campinas, Brazil)

    Objective: To assess the effectiveness of cough in Parkinson’s Disease (PD) patients in mild, moderate and severe disease stages. Background: Parkinson's Disease is the second…
  • 2023 International Congress

    Clinico-genetic analysis of patients with Parkinson’s disease and GBA mutations from a tertiary care teaching centre in India

    S. Kamath, V. Holla, P. Phulpagar, N. Kamble, R. Yadav, B. Muthusamy, PK. Pal (Bangalore, India)

    Objective: To describe the clinico-genetic association of PD patients with heterozygous GBA mutations (PDwG). Background: Parkinson’s disease (PD) is currently understood to be the outcome…
  • 2023 International Congress

    A Retrospective Review of Amantadine in Progressive Supranuclear Palsy

    N. Mcfarland, R. Farrukh, S. Mahn (Gainesville, USA)

    Objective: To determine the efficacy and tolerability of amantadine in Progressive supranuclear palsy (PSP). Background: PSP is one of the most common atypical parkinsonian disorders,…
  • 2023 International Congress

    Gut dysbiosis in Indian Parkinson’s Disease Patients with Constipation

    S. Pavan, M. Ballal, A. Prabhu, B. Das, A. Mutreja, K. Vasudevan (Manipal, India)

    Objective: To analyse the gut microbiome and explore dysbiosis in Indian Parkinson’s Disease patients with and without constipation. Background: Global studies have associated gut dysbiosis…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley